Subject Disposition at Week 24 (Treated Analysis Set).
收藏数据链接：
官方服务：
资源简介：
*Adverse events leading to study drug discontinuation: Immediate Switch: emergent to EFV/FTC/TDF—anxiety; insomnia; night sweatsDelayed Switch: emergent to ABC/3TC + EFV (baseline to Wk12)—depressionDelayed Switch: emergent to EFV/FTC/TDF (Wk 12 to Wk 24)—sleep disorder; urticaria The proportion of subjects discontinuing due to adverse events at week 12 was the same in both groups (n = 1; 1.3%)Immediate Switch: emergent to EFV/FTC/TDF—anxiety; insomnia; night sweatsDelayed Switch: emergent to ABC/3TC + EFV (baseline to Wk12)—depressionDelayed Switch: emergent to EFV/FTC/TDF (Wk 12 to Wk 24)—sleep disorder; urticariaSubject Disposition at Week 24 (Treated Analysis Set).
创建时间：
2015-12-03
